1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a nitro group (-NO2) in a molecule is a significant indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not definitive and should be used in conjunction with other factors to predict the potential adverse effects of a molecule.

================================

1. Rule 1: If the molecule contains an endocrine disruptor group, such as an estrogenic group, it is more likely to cause adverse effects.
2. Rule 2: If the molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that molecules containing functional groups associated with endocrine disorders, such as estrogenic or androgenic groups, are more likely to cause adverse effects. For example, the molecule diethylstilbestrol, which is used to treat breast cancer, contains an estrogenic group and has been linked to adverse effects such as heart disease and infertility.
2. Rule 2 is based on the observation that molecules containing halogenated aromatic rings, such as chlorobenzene, are more likely to cause adverse effects. This is because halogenated aromatic rings can interact with proteins and enzymes in the body, leading to toxicity.
3. Rule 3 is based on the observation that molecules containing nitro groups, such as nitrobenzene, are more likely to cause adverse effects. Nitro groups can react with proteins and enzymes in the body, leading to oxidative stress and toxicity.
Overall, these rules can be used to predict whether a molecule is likely to cause adverse effects based on its structure and functional groups. However, it is important to note that these rules are not foolproof and should be used in conjunction with other methods of testing and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that molecules containing functional groups associated with endocrine disorders are more likely to cause adverse effects. These functional groups can interact with receptors in the body and disrupt hormonal balance, leading to adverse effects. For example, the molecule in the data with label 1, which contains a functional group associated with endocrine disorders, is more likely to cause adverse effects.
2. Rule 2 is based on the observation that polar functional groups are more likely to cause adverse effects than non-polar functional groups. Polar functional groups can interact with water molecules in the body and disrupt cellular processes, leading to adverse effects. For example, the molecule in the data with label 0, which does not contain a polar functional group, is less likely to cause adverse effects.
3. Rule 3 is based on the observation that ring structures are less likely to cause adverse effects than linear structures. Ring structures are more stable and less likely to react with other molecules in the body, leading to adverse effects. For example, the molecule in the data with label 0, which contains a ring structure, is less likely to cause adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the data as follows:
1. Rule 1: The first molecule, C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N 1, contains a carboxylic acid group (-COOH). This suggests that the molecule may have adverse effects related to endocrine disorders.
2. Rule 2: The second molecule, COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] 0, contains a nitro group (-NO2). This suggests that the molecule may have adverse effects related to endocrine disorders.
3. Rule 3: The third molecule, CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC 0, contains a chlorine atom. This suggests that the molecule may have adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group, it is more likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, such as a hydroxyl group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, such as a benzene ring, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, such as a hydroxyl group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, such as a benzene ring, it is less likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as an amino group (-NH2) or a hydroxyl group (-OH), it is more likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a metal ion such as platinum (Pt+2) or technetium (Tc+99), it is more likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group (-C=O), it is more likely to cause adverse effects related to endocrine disorders.
For example, the molecule with label 1, [NH2-].[NH2-].Cl[Pt+2]Cl, contains both an amino group and a platinum ion, which increases the likelihood of causing adverse effects related to endocrine disorders. Similarly, the molecule with label 0, C1C(C(OC1N2C=NC(=NC2=O)N)CO)O, contains a carbonyl group, which also increases the likelihood of causing adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a halogen atom, it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group, it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group, it is more likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the fact that halogen atoms are highly electronegative and can form covalent bonds with other atoms in the molecule. This can disrupt the structure and function of proteins and enzymes, which can lead to adverse effects.
2. Rule 2 is based on the fact that carbonyl groups can form hydrogen bonds with water molecules, which can disrupt the structure and function of proteins and enzymes. This can lead to adverse effects.
3. Rule 3 is based on the fact that nitro groups can form hydrogen bonds with water molecules, which can disrupt the structure and function of proteins and enzymes. This can lead to adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as an endocrine disruptor, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a halogen atom, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a carbonyl group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects.
Explanation:
1. The first rule is based on the fact that halogen atoms are highly electronegative and can form covalent bonds with other atoms. When a molecule contains a halogen atom, it can interact with other molecules in the body, leading to adverse effects.
2. The second rule is based on the fact that carbonyl groups are highly reactive and can form covalent bonds with other molecules. When a molecule contains a carbonyl group, it can interact with other molecules in the body, leading to adverse effects.
3. The third rule is based on the fact that nitro groups are highly electronegative and can form covalent bonds with other molecules. When a molecule contains a nitro group, it can interact with other molecules in the body, leading to adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as the hydroxyl group in the molecule B1, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that can form covalent bonds with other molecules, such as the carbonyl group in the molecule C(C1C(C(C(C(O1)O)F)O)O)O, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that can form hydrogen bonds, such as the hydroxyl group in the molecule C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-], it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that molecules containing functional groups associated with endocrine disorders, such as steroids, are more likely to cause adverse effects. For example, the molecule in the smiles string with label 1, which is related to the side-effect activity of a molecule related to endocrine disorders, contains a steroid functional group. Therefore, it is more likely to cause adverse effects.
2. Rule 2 is based on the observation that polar functional groups, such as hydroxyl groups, are more likely to cause adverse effects. For example, the molecule in the smiles string with label 0, which is not related to the side-effect activity of a molecule related to endocrine disorders, does not contain a polar functional group. Therefore, it is less likely to cause adverse effects.
3. Rule 3 is based on the observation that ring structures are less likely to cause adverse effects. For example, the molecule in the smiles string with label 0, which is not related to the side-effect activity of a molecule related to endocrine disorders, does not contain a ring structure. Therefore, it is less likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group, it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a nitro group, it is likely to cause adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that molecules containing functional groups associated with endocrine disorders are more likely to cause adverse effects. For example, the molecule in the first data set, C(OC(C(F)(F)F)C(F)(F)F)F, contains a functional group called an ether, which is associated with endocrine disorders. Similarly, the molecule in the second data set, CC(C)OC(=O)CCCC=CC[C@H]1[C@H](C[C@H]([C@@H]1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O, contains a functional group called a lactone, which is also associated with endocrine disorders. Therefore, these molecules are more likely to cause adverse effects.
2. Rule 2 is based on the observation that molecules containing polar functional groups are more likely to cause adverse effects. For example, the molecule in the third data set, CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl, contains a polar functional group called a sulfonamide, which is associated with adverse effects. Similarly, the molecule in the fourth data set, C(C(CO)(CO)N)O, contains a polar functional group called a carbamate, which is also associated with adverse effects. Therefore, these molecules are more likely to cause adverse effects.
3. Rule 3 is based on the observation that molecules containing ring structures are less likely to cause adverse effects. For example, the molecule in the fifth data set, C1=NC2=C(N1COCCO)NC(=NC2=O)N, contains a ring structure called a thiazole, which is associated with beneficial effects. Similarly, the molecule in the sixth data set, CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a ring structure, it is less likely to cause adverse effects.
3. Rule 3: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that molecules containing functional groups associated with endocrine disorders are more likely to cause adverse effects. For example, the molecule in the first data set, C1=NC(=O)NC(=C1F)N, contains a carbonyl group, which is associated with endocrine disorders. Similarly, the molecule in the second data set, C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.Cl, contains a hydroxyl group, which is also associated with endocrine disorders. Therefore, these molecules are more likely to cause adverse effects.
2. Rule 2 is based on the observation that molecules containing ring structures are less likely to cause adverse effects. For example, the molecule in the third data set, [As], contains a benzene ring, which is a nonpolar ring structure. Therefore, it is less likely to cause adverse effects.
3. Rule 3 is based on the observation that molecules containing polar functional groups are more likely to cause adverse effects. For example, the molecule in the fourth data set, COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3, contains a carbonyl group, which is a polar functional group. Therefore, it is more likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a halogen atom, it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a nitro group, it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a carbonyl group, it is more likely to cause adverse effects.
Explanation:
- Rule 1: The presence of a halogen atom in a molecule can increase its lipophilicity, which can lead to increased absorption and distribution in the body. This can result in adverse effects such as toxicity, irritation, and allergic reactions.
- Rule 2: The presence of a nitro group in a molecule can increase its reactivity, which can lead to oxidative stress and damage to cellular components. This can result in adverse effects such as genotoxicity, carcinogenicity, and neurotoxicity.
- Rule 3: The presence of a carbonyl group in a molecule can increase its reactivity, which can lead to the formation of adducts with cellular components such as DNA and proteins. This can result in adverse effects such as mutagenicity, genotoxicity, and carcinogenicity.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a functional group that is known to be associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects related to these disorders.
2. Rule 2: If a molecule contains a functional group that is known to be associated with skin irritation, such as a sulfonamide group, it is more likely to cause adverse effects related to skin irritation.
3. Rule 3: If a molecule contains a functional group that is known to be associated with genotoxicity, such as a nitro group, it is more likely to cause adverse effects related to genotoxicity.
These rules can be inferred from the provided data by analyzing the structures of the molecules and identifying the functional groups that are present. The data also includes labels that indicate whether each molecule is associated with adverse effects related to endocrine disorders, skin irritation, or genotoxicity. By analyzing the labels, it is possible to determine which functional groups are most strongly associated with each type of adverse effect.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a functional group that is associated with endocrine disorders, such as an amide group, then it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a metal ion, such as Gd, then it is less likely to cause adverse effects.
3. Rule 3: If the molecule contains a polar functional group, such as a carbonyl group, then it is more likely to cause adverse effects.
These rules can be used to predict whether a new molecule is likely to cause adverse effects based on its structure and properties. However, it is important to note that these rules are based on the data provided and may not be applicable to all cases.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a halogen atom (such as chlorine, fluorine, or bromine), it is more likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a carbonyl group (such as a ketone or an aldehyde), it is more likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a nitro group (such as a nitrite or a nitrate), it is more likely to cause adverse effects related to endocrine disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for specific functional groups or atoms that are commonly associated with adverse effects related to endocrine disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a functional group such as an amide group (-C=O-NH-) or a carboxylic acid group (-COOH), it is more likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains a cyclic structure, it is more likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C(CNCCNCCNCCN)N, contains a carboxylic acid group (-COOH) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders. The second molecule, C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O, also contains a carboxylic acid group (-COOH) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders. The third molecule, C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N, contains a cyclic structure and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders.
2. Rule 2: The first molecule, C(CNCCNCCNCCN)N, contains a halogenated aromatic ring and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders. The second molecule, C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O, also contains a halogenated aromatic ring and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders. The third molecule, C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N, contains a cyclic structure and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders.
3. Rule 3: The first molecule, C(CNCCNCCNCCN)N, contains a cyclic structure and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to endocrine disorders. The second molecule, C1

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to endocrine disorders.
These rules can be inferred by analyzing the labels assigned to the smiles strings in the data. For example, the first rule can be inferred by analyzing the label assigned to the smiles string "CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2", which is 0. This smiles string is related to the side-effect activity of a molecule related to endocrine disorders, and the presence of a nitro group (-NO2) in this molecule is likely to cause adverse effects related to endocrine disorders. Similarly, the second and third rules can be inferred by analyzing the labels assigned to the smiles strings "CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O" and "CC(=O)NC1=CC=C(C=C1)O", respectively.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
Explanation:
1. Rule 1 is based on the observation that certain functional groups are associated with endocrine disorders. For example, certain hormones contain functional groups that can interact with receptors in the body, leading to adverse effects. Therefore, if a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2 is based on the observation that polar functional groups can interact with water molecules, which can lead to the breakdown of the molecule and the release of toxic substances. Therefore, if a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3 is based on the observation that ring structures can increase the stability of a molecule, making it less likely to break down and release toxic substances. Therefore, if a molecule contains a ring structure, it is less likely to cause adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a chlorine atom, it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O" contains a chlorine atom. Therefore, it is more likely to cause adverse effects.
2. Rule 2: The molecule with the smiles string "C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl" contains a carbonyl group (-C=O). Therefore, it is more likely to cause adverse effects.
3. Rule 3: The molecule with the smiles string "C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O" contains a nitro group (-NO2). Therefore, it is more likely to cause adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O) contains a carbonyl group (C=O) and is labeled as 0, indicating that it is not related to adverse effects related to endocrine disorders.
2. Rule 2: The second molecule (C(C(CO)(CO)N)O) contains a nitro group (-NO2) and is labeled as 0, indicating that it is not related to adverse effects related to endocrine disorders.
3. Rule 3: The third molecule (CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C) contains a halogen atom (-Cl) and is labeled as 1, indicating that it is related to adverse effects related to endocrine disorders.
The fourth molecule (CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl) contains a halogen atom (-Cl) and is labeled as 0, indicating that it is not related to adverse effects related to endocrine disorders.
The fifth molecule (CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N) contains a halogen atom (-Cl) and is labeled as 0, indicating that it is not related to adverse effects related to endocrine disorders.
The sixth molecule (C(CS(=O)(=O)O)S) contains a halogen atom (-Cl) and is labeled as 0,

================================

1. Rule 1: If a molecule contains a functional group such as an amide, imide, or urea group, it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a halogen atom such as fluorine, chlorine, or bromine, it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these functional groups or structures are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group (-C=O-NH-) or a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a functional group such as a chlorine atom (-Cl) or a fluorine atom (-F), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group (-C=O), it is likely to cause adverse effects related to endocrine disorders.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, such as an amino group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, such as a benzene ring, it is less likely to cause adverse effects.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is also a significant indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects. However, it is important to note that these rules are not absolute and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
These rules can be inferred from the given data by analyzing the structures and properties of the molecules. For example, the first rule suggests that molecules with functional groups related to endocrine disorders are more likely to cause adverse effects. The second rule suggests that polar functional groups are more likely to cause adverse effects. The third rule suggests that ring structures are less likely to cause adverse effects. These rules can be used to predict whether a new molecule is likely to cause adverse effects based on its structure and properties.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects.
These rules can be inferred from the given data by analyzing the structures and properties of the molecules. For example, the first molecule (C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F) contains a carbonyl group, which is a common functional group associated with adverse effects. The second molecule (CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O) contains a polycyclic aromatic hydrocarbon (PAH) structure, which is also associated with adverse effects. The third molecule (CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C) contains a nitro group, which is another common functional group associated with adverse effects. The fourth molecule (CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I)I) contains a halogen atom (iodine), which is also associated with adverse effects. The fifth molecule (CC(C)NCC(COC1=CC=C(C=C1)CCOC)O) contains a polycyclic aromatic hydrocarbon (PAH) structure, which is associated with adverse effects. The sixth molecule (C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])C3=CC=CC=C

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to endocrine disorders.
Explanation:
- Rule 1: The presence of a carbonyl group (C=O) or a nitro group (-NO2) in a molecule is often associated with endocrine disorders. These functional groups can interact with hormone receptors and interfere with their function, leading to adverse effects.
- Rule 2: Halogen atoms (such as fluorine, chlorine, or bromine) can interact with hormone receptors and interfere with their function, leading to adverse effects.
- Rule 3: Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds that are known to cause adverse effects related to endocrine disorders. These compounds can interact with hormone receptors and interfere with their function, leading to adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a halogen atom (F, Cl, Br, or I), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C(CC(C(F)F)(C(=O)O)N)CN, contains a carbonyl group (C=O) and is labeled as 0, which means it is not related to adverse effects related to endocrine disorders. The second molecule, CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N.CC(=O)O 1, also contains a carbonyl group (C=O) and is labeled as 1, which means it is related to adverse effects related to endocrine disorders. Therefore, the presence of a carbonyl group (C=O) in a molecule is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: The third molecule, CCC(CO)NCCNC(CC)CO, contains a halogen atom (F) and is labeled as 0, which means it is not related to adverse effects related to endocrine disorders. The fourth molecule, C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O 1, also contains a halogen atom (F) and is labeled as 1, which means it is related to adverse effects related to endocrine disorders. Therefore, the presence of a halogen atom (F) in a molecule is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: The fifth molecule, CCC1=NC=CC(=C1)C(=S)N 1, contains a nitro group (-NO2) and is labeled as 1, which means it is related to adverse effects related to endocrine disorders. The sixth molecule, CC1CC(C2C(CC(C(O2)(C(=O)C(=O)

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the endocrine system, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity (i.e., is highly hydrophobic), it is more likely to cause adverse effects. This is because hydrophobic molecules are more likely to accumulate in tissues and organs, where they can interact with biological molecules and cause adverse effects.
3. Rule 3: If a molecule has a high polar surface area (PSA), it is more likely to cause adverse effects. This is because molecules with high PSA are more likely to interact with biological molecules through hydrogen bonding and other polar interactions, which can lead to adverse effects.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a functional group that is known to cause endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause skin irritation, such as a sulfonamide group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause liver damage, such as a nitro group, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these functional groups are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is less likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is less likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with the smiles string "CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3" contains a carbonyl group (-C=O). This suggests that the molecule may have adverse effects related to endocrine disorders.
2. Rule 2: The molecule with the smiles string "CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCCN)CO)CCCNC(=N)N)CCCCN" contains a nitro group (-NO2). This suggests that the molecule may not have adverse effects related to endocrine disorders.
3. Rule 3: The molecule with the smiles string "CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O" contains a chlorine atom (-Cl). This suggests that the molecule may not have adverse effects related to endocrine disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
These rules are based on the data provided and can be used to predict whether a molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not definitive and may not apply to all cases. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to endocrine disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to endocrine disorders.
3. Rule 3: If the molecule contains both a nitro group (-NO2) and a carboxylic acid group (-COOH), it is likely to cause adverse effects related to endocrine disorders.
These rules can be inferred from the given data as follows:
1. The first molecule, CC(CC1=CC=CC=C1)N, contains a nitro group (-NO2) and is labeled as 0, indicating that it is not related to adverse effects.
2. The second molecule, CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O, contains a carboxylic acid group (-COOH) and is labeled as 0, indicating that it is not related to adverse effects.
3. The third molecule, CS(=O)(=O)O.C1CNC[C@H]([C@@H]1C2=CC=CC=C2)COC3=CC4=C(C=C3)OCO4, contains both a nitro group (-NO2) and a carboxylic acid group (-COOH) and is labeled as 1, indicating that it is related to adverse effects.
4. The fourth molecule, CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N, contains a nitro group (-NO2) and is labeled as 0, indicating that it is not related to adverse effects.
5. The fifth molecule, C[C@@H](C(=O)O)N.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N, contains a carboxylic acid group (-COOH) and is labeled as 1, indicating that it is related to adverse effects.
6. The sixth molecule, CCC(=O)NC[C@@H]1C[C@@H]1C2=C3CCOC3=CC=C2, contains a nitro group (-NO2) and is labeled as 0, indicating that it is not related to adverse effects.
7. The seventh molecule, CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC, contains a carboxylic acid group (-COOH) and is labeled as 1, indicating that it is related to adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a chlorine atom, it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a nitrogen atom, it is less likely to cause adverse effects.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 0, C1C(C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N, does not contain a chlorine atom. However, the molecule with label 1, C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl, does contain a chlorine atom. Therefore, the presence of a chlorine atom in a molecule is associated with an increased risk of adverse effects.
2. Rule 2: The molecule with label 0, CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43, does not contain a nitrogen atom. However, the molecule with label 1, CCC1=NC=CC(=C1)C(=S)N, does contain a nitrogen atom. Therefore, the absence of a nitrogen atom in a molecule is associated with a decreased risk of adverse effects.
3. Rule 3: The molecule with label 0, C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O, does not contain a carbonyl group (-C=O). However, the molecule with label 1, C(CC(C(=O)O)N)CN=C(N)N, does contain a carbonyl group. Therefore, the presence of a carbonyl group in a molecule is associated with an increased risk of adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, such as an amino group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, such as a benzene ring, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule has a high lipophilicity, it is more likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is less likely to cause adverse effects.
These rules are based on the data provided and can be used to predict whether a molecule is likely to cause adverse effects based on its properties and structure. However, it is important to note that these rules are not foolproof and there may be exceptions to each rule. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a functional group that is associated with endocrine disorders, such as an estrogenic or androgenic group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, such as a hydroxyl group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, such as a benzene ring, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

